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Abstract
Background: Polycomb repressive complex 1 (PRC1) core member Ring1b/Rnf2, with ubiquitin E3 ligase activity towards
histone H2A at lysine 119, is essential for early embryogenesis. To obtain more insight into the role of Ring1b in early
development, we studied its function in mouse embryonic stem (ES) cells.
Methodology/Principal Findings: We investigated the effects of Ring1b ablation on transcriptional regulation using Ring1b
conditional knockout ES cells and large-scale gene expression analysis. The absence of Ring1b results in aberrant expression
of key developmental genes and deregulation of specific differentiation-related pathways, including TGFbeta signaling, cell
cycle regulation and cellular communication. Moreover, ES cell markers, including Zfp42/Rex-1 and Sox2, are downregulated.
Importantly, retained expression of ES cell regulators Oct4, Nanog and alkaline phosphatase indicates that Ring1b-deficient
ES cells retain important ES cell specific characteristics. Comparative analysis of our expression profiling data with previously
published global binding studies shows that the genes that are bound by Ring1b in ES cells have bivalent histone marks, i.e.
both active H3K4me3 and repressive H3K27me3, or the active H3K4me3 histone mark alone and are associated with CpG-
‘rich’ promoters. However, deletion of Ring1b results in deregulation, mainly derepression, of only a subset of these genes,
suggesting that additional silencing mechanisms are involved in repression of the other Ring1b bound genes in ES cells.
Conclusions: Ring1b is essential to stably maintain an undifferentiated state of mouse ES cells by repressing genes with
important roles during differentiation and development. These genes are characterized by high CpG content promoters and
bivalent histone marks or the active H3K4me3 histone mark alone.
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Introduction
PcG proteins have initially been identified in Drosophila as
transcriptional repressors required for correct expression of
homeotic (Hox) genes. By means of chromatin remodeling, PcG
proteins maintain stable gene repression to ensure proper
embryonic development. In mammals, two biochemically and
functionally distinct PcG core complexes have been identified [1].
Mammalian polycomb repressive complex 1 (PRC1) consists of
close homologs of the Drosophila PRC1 core members Ph, Pc, Psc
and dRing [1,2]. Ring1b/Rnf2, the mouse homolog of dRing, acts
as a ubiquitin E3 ligase towards histone H2A at lysine 119
resulting in mono-ubiquitinated H2A (uH2A) [3,4]. Ezh2/Kmt6,
a methyltransferase that trimethylates histone H3 at lysine 27
(H3K27me3), acts in complex with Suz12 and Eed, constituting
Polycomb repressive complex 2 (PRC2) [5–7]. PRC1 and PCR2
do not physically interact, but the Ezh2 catalyzed histone mark
H3K27me3 is recognized by PRC1 member Pc, providing a
mechanism of communication between the two complexes [8].
Furthermore, PRC1 binding to chromatin requires PRC2,
although PRC2-independent recruitment of PRC1 is also reported
[9,10]. The counteracting trithorax group (TrxG) proteins mediate
an active transcriptional state by methylation of histone H3 at
lysine 4 (H3K4me3) [2].
Proper expression of PRC2 proteins is essential during early
embryonic development,, since mice lacking one of these proteins
die due to gastrulation defects [11–13]. In contrast, PRC1
members appear to be more important during later stages of
development, with the clear exception of Ring1b, which evokes an
early embryonic lethal phenotype similar to PRC2 null mice [14–
18]. PcG proteins were shown to be important for self-renewal and
maintaining pluripotency of ES cells [19–21]. ES cells are derived
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can self-renew and maintain a pluripotent, undifferentiated state
under the right conditions in vitro, while retaining the capacity to
differentiate into every cell type required during development in
vitro and in vivo when reintroduced back into a host blastocyst [23].
Genome-wide and candidate-based studies revealed that PcG
proteins maintain this undifferentiated state of ES cells through
direct repression of developmental genes [21,24–27]. Develop-
mental genes are largely associated with bivalent (i.e. both
repressive H3K27me3 and active H3K4me3) histone marks and
are silent or expressed at very low levels in ES cells [28–30].
Bivalent domains tend to resolve during development [28–30].
Therefore, it is suggested that this bivalent chromatin state poises
genes for transcriptional activation (loss of H3K27me3) or
prolonged repression (loss of H3K4me3 or both marks) during
later developmental stages. Only recently, it was shown that
Ring1b-mediated uH2A deposition at repressed bivalent genes
restrains a poised RNA polymerase II (RNAPII) configuration
[31]. Conditional deletion of Ring1b and subsequent loss of uH2A
from the promoter and coding region results in release of poised
RNAPII and gene derepression. More evidence for a direct role of
uH2A in negative transcriptional regulation was found by another
group, which investigated the role of histone H2A E3 ligase 2A-
HUB in repressing chemokine genes in human monocytes [32].
They show that the presence of uH2A in the promoter-proximal
region physically blocks recruitment of FACT, thereby causing
RNAPII-dependent transcription elongation to pause.
To explore the role of Ring1b in regulation of gene expression
during early development, we analyzed genome-wide changes in
gene transcription following deletion of Ring1b in ES cells.
Hereto, we employed an inducible knockout system and
performed a genome-wide screen using microarrays to identify
genes governed by Ring1b. We identify several processes and
pathways differentially regulated in Ring1b-deficient ES cells,
which are implicated in differentiation and embryogenesis.
Importantly, we find that Ring1b-deficient ES cells retain
expression of key stem cell regulators Oct4 and Nanog. Finally,
by comparing our expression data with previously published global
binding studies, we find that Ring1b preferentially represses genes
with high CpG-content promoters and bivalent or H3K4me3
histone marks. This suggests that Ring1b has an important role in
maintaining an undifferentiated state of ES cells. Furthermore, this
study provides more insight in the characteristics of the genes that
are under direct transcriptional control of Ring1b in ES cells.
Results
Generating Ring1b conditional knockout mouse
embryonic stem cells
To gain insight in the role of Ring1b in ES cells, we generated
Ring1b conditional knockout mouse ES cells. Previously, we have
shown that deletion of the RINGfingerdomainof Ring1b, encoded
by exon 3 and 4, generates a functional null allele [17]. Ring1b
conditional knockout (Ring1b
2/Lox) ES cells were then generated
by a second targeting round in Ring1b
+/2 ES cells [17] using a
targeting vector, which introduced loxP sequences flanking these
exons (Figure 1A; details in Materials and Methods). To generate
inducible Ring1b
2/Lox ES cells, we targeted a 4-hydroxytamoxifen
(4-OHT) inducible R26CreER
T2 construct (Cre-recombinase fused
to a mutated ligand binding domain of the human estrogen
receptor) to the ROSA26 locus of Ring1b
2/Lox ES cells, hereafter
named Ring1b
2/Lox;CreER
T2 ES cells. The presence of loxP
sequences in the genomic locus of Ring1b did not alter the
expression of Ring1b in ES cells. Accordingly, Ring1b
2/Lox and
Ring1b
2/Lox;CreER
T2 mice developed indistinguishable from wild
type mice (E.B, M.v.L, unpublished results).
Addition of 4-OHT to the culture medium resulted in recombi-
nationoftheRing1bconditionalalleleinRing1b
2/Lox;CreER
T2EScells
and subsequent depletion of Ring1b protein as was shown by
Southern and Western blot analysis (Figure 1B, 1C). We observed
cellular detachment and apoptosis concurrent with an increase in
cells with a differentiated phenotype after deleting Ring1b in
Ring1b
2/Lox;CreER
T2 ES cells, but not in similarly treated
Ring1b
+/+;CreER
T2 control ES cells. Based on Annexin V staining
followed by flow cytometric analysis, about 83% of all
Ring1b
2/Lox;CreER
T2 ES cells were undergoing apoptosis four days
following 4-OHT treatment (data not shown). Of the adherent
populationonly15%wasAnnexinVpositive,comparedto5%ofthe
untreated population (data not shown). We therefore focused our
studies on the immediate early effects of the first days following Cre-
mediated deletion of Ring1b in the viable, adherent ES cells.
Ring1b is required for mono-ubiquitination of H2A in ES
cells
SinceRing1bisaubiquitinE3ligaseforhistoneH2Aatlysine119,
we studied the effect of Ring1b deletion on the levels of uH2A.
Western blot analysis showed that uH2A levels decreased to almost
undetectablelevelsafterdeletionofRing1bfromRing1b
2/Lox;CreER
T2
ES cells (Figure 1C). In addition, immunofluorescence stainings
confirmed that uH2A was lost in ES cells that had lost Ring1b
expression (Figure 2A). The same held true for mouse embryonic
fibroblasts(MEFs)derivedfromRing1b
2/Lox;CreER
T2mouseembryos,
which showed no uH2A immunofluorescence staining in Ring1b-
negative cells (Figure S1). Immunofluorescence stainings for
H3K27me3, the polycomb repressive mark set by PRC2 member
Ezh2,showedthatthismarkwaspresentinallcells(Figure2B).These
results confirm that Ring1b is the main E3 ligase for mono-
ubiquitination of H2A inbothmouse EScells andMEFsand suggest
that deletion of Ring1b does not affect H3K27 trimethylation.
Ring1b deficiency affects expression of other PRC1 core
members
Studies in Drosophila, mouse and human cells have shown that
PcG genes themselves are PcG protein binding targets, suggesting
auto-regulation within the PcG family [21,25,33]. We therefore
examined the effect of Ring1b deletion on other PRC1 and PRC2
members in ES cells. Microarray analysis (described in more detail
in the following section) showed that the transcript levels of Ring1b
and Phc1/Mph1 were significantly downregulated over time, and
correspondingly decreased in protein levels (Figure 3A, Table S1).
Interestingly, PRC1 member Bmi1 was derepressed transcription-
ally in the absence of Ring1b, but its protein levels were down-
regulated, suggesting that Bmi1 is post-transcriptionally regulated
by Ring1b (Figure 3B). This is consistent with observations by
others [34], and may be explained by the fact that interaction
between Bmi1 and Ring1b protects both proteins from ubiquitin-
mediated degradation [35]. The effect of loss of Ring1b on other
PRC1 core members may explain the severity of the Ring1b
mouse knockout phenotype compared to knockout models of other
PRC1 members [14–18]. Other polycomb group genes of which the
transcription had increased significantly were Epc1, Phf1,a n dPhc2
(Table S1). No effects were observed on the protein or transcript
levels of PRC2 members Ezh2 and Eed, or the levels of H3K27me3,
which is in agreement with the immunofluorescence analysis
(Figure 3A, 3B, Table S1). The effect on PcG protein and transcript
levels after loss of Ring1b is in agreement with an earlier study
performed in established Ring1b-deficient ES cells, with the
Ring1b Regulates ES Cell Fate
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might thereforereflect anindirecteffectofacute lossof Ring1b inES
cells. These results suggest that deletion of Ring1b affects the
transcript and protein levels of members of PRC1, but not of PRC2,
and underscores the importance of Ring1b for PRC1 stability.
Regulation of developmental processes through
derepression of Ring1b bound genes
To obtain insight in the genome-wide effects on gene
transcription after deletion of Ring1b in ES cells, we performed
microarray analysis. We analyzed the temporal changes in gene
transcription in Ring1b
2/Lox;CreER
T2 ES cells one to four days after
deletion of Ring1b. As a reference, we used Ring1b
+/+;CreER
T2 ES
cells similarly treated with 4-OHT to correct for any effects
induced by 4-OHT or CreER
T2. We identified 2365 differentially
regulated genes, i.e. genes that were significantly (p,0.05
according to the Rosetta-error model, for details see Materials
and Methods) up- or downregulated (7%; 2365/31769; Figure 4A,
4B, Table S1). The reliability of the microarray data was
confirmed by quantitative real-time PCR analysis (QPCR) on a
selection of 18 genes (Figure 4D).
To gain insight into the processes that are deregulated in
absence of Ring1b in mouse ES cells, we analyzed the deregulated
genes based on their ontology classification. To this end, we
employed the gene ontology (GO) tool BiNGO to determine
which GO categories are statistically overrepresented. By mapping
the predominant functional GO categories in a hierarchical graph
BiNGO facilitates insight in the hierarchical structure and
relations between the ontologies [36]. We found that the outliers
were involved in various processes, of which the most downstream
in the GO-tree were: ‘organ development’, ‘organ morphogenesis’,
‘nucleosome assembly’, ‘regulation of cellular physiological
processes’, ‘glyconeogenesis’, and ‘cell cycle’ (Figure 4E; for a
graphical overview of the overrepresented GO categories, see
Figure 1. Generating Ring1b conditional knockout ES cells. (A) Schematic overview of the Ring1b locus targeting strategy in mouse Ring1b
+/2
ES cells. The wild type Ring1b allele is shown with main restrictions sites, introns and exons, in the targeted genomic region. The Ring1b
LoxHyg allele
was generated by targeting a floxed exon3+4/Hygromycin replacement vector to the wild type Ring1b locus of the Ring1b
+/2 ES cells. The
hygromycin cassette allowed for selection after the initial targeting and was removed by transiently expressing adenoviral Cre to generate the
conditional Ring1b
Lox allele. Acute loss of Ring1b from Ring1b
Lox ES cells was induced by adding 4-OHT to the medium to activate CreER
T2 (Cre-
recombinase fused to a mutated ligand binding domain of the human estrogen receptor (ER), targeted to the ROSA locus, not shown) resulting in
deletion of exons 3 and 4, represented as the Ring1b
Del allele. Exons are indicated by white boxes with the corresponding exon number, loxP
sequences by black triangles, and HYG indicates the hygromycin cassette. Main restriction sites are indicated (H=HindIII, E=EcoRI, X=XhoI) as well
as the location of the 59end probe used for Southern blot analysis. (B) Southern blot analysis of HindIII digested genomic DNA of Ring1b
2/Lox;CreER
T2
ES cells showing recombination of the Ring1b
Lox allele following treatment with 4-OHT for the indicated time in days. The 59end probe visualizes the
conventional knockout allele (5 kb), the conditional Lox allele (7 kb) and the recombined Del allele (4 kb). (C) Western blot analysis showing loss of
Ring1b protein and uH2A in Ring1b
2/Lox;CreER
T2 ES cells following treatment with 4-OHT for the indicated time in days. Tubulin serves as a loading
control.
doi:10.1371/journal.pone.0002235.g001
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confirm that Ring1b is involved in regulating cell cycle,
developmental and chromatin-related processes and indicate that
deletion of Ring1b affects glyconeogenesis and the regulation of
cellular physiological processes. Given that loss of Ring1b affects
the undifferentiated state of ES cells, the regulated processes are
likely to include genes that are deregulated due to indirect effects.
By using a genome-wide ChIP-on-chip analysis Boyer and
colleagues identified genes that are bound by Ring1b in mouse ES
cells [21]. By combining our microarray expression data with the
data from this Ring1b binding study, we were able to determine
which genes were direct transcriptional targets of Ring1b. Of the
1219 Ring1b bound genes, identified by Boyer and colleagues, 1078
were represented on our microarray. Remarkably, we found that
only a subset of 141 Ring1b bound genes had significantly changed
expression (13% (141/1078). These genes were predominantly
upregulated, which is in agreement with Ring1b being a transcrip-
tional repressor (Figure 4C). The partial derepression implies that
other regulatory mechanisms are active at the other Ring1b target
genes in addition to Ring1b, and reflects that a subset of genes is
deregulated due to indirect effects of loss of Ring1b in ES cells.
Next, we assessed which of the deregulated genes within an
overrepresented GO category (most down-stream in the GO-tree,
see also Figure S2) were bound by Ring1b. We found that on
average 30% of the deregulated genes within an enriched ontology
was bound by Ring1b, in particular in the ontologies organ
development and morphogenesis, nucleosome assembly, and
regulation of cellular physiological process (Figure 4F). This was
substantially higher than what would be expected considering that
only 6% (141/2365) of all deregulated genes was bound by Ring1b.
This indicates that Ring1b is involved in direct transcriptional
regulation of a substantial large fraction of the deregulated genes in
these ontologies. Together, these data suggest that Ring1b is
specifically important for dynamic repression of developmental,
chromatin-related, cell cycle and metabolic genes in ES cells.
Regulation of specific differentiation-related pathways in
Ring1b-deficient ES cells
The analysis based on the ontology classification shows that
absence of Ring1b results in aberrant expression of genes involved
in developmental and various cellular processes. We set out to
identify specific pathways that are affected in Ring1b-deficient ES
cells. To remain unbiased in the analysis of our set of outliers, we
used the bioinformatics tool DAVID, which uses information of
well-defined pathways available in the KEGG pathway database
(http://david.abcc.ncifcrf.gov). Interestingly, we found that the
Figure 2. Deletion of Ring1b results in loss of uH2A but not
H3K27me3. Examples of immunofluorescence stainings in
Ring1b
2/Lox;CreER
T2 ES cells showing loss of uH2A (A), but not
H3K27me3 (B) in cells that have lost Ring1b four days following 4-
OHT treatment.
doi:10.1371/journal.pone.0002235.g002
Figure 3. Downregulation of protein levels of PRC1, but not
PRC2, following Ring1b deletion in ES cells. Western blot analysis
of total cell protein extracts (A) or nuclear extracts (B) of
Ring1b
2/Lox;CreER
T2 ES cells shows that deletion of Ring1b results in
downregulation of Phc1/Mph1 and Bmi1 protein levels, but not of Ezh2,
Eed or H3K27me3 levels following treatment with 4-OHT for the
indicated number of days.
doi:10.1371/journal.pone.0002235.g003
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of ES cells. A selection is listed in Table 1. A complete overview of
the pathway analysis can be found in Table S3.
Most revealing was the identification of the TGFbeta signaling
pathway of which Bmp/Id signaling (derepressed Bmp7, Bmpr1a,
Id1, Id2, and Id3) and Nodal/Pitx2 signaling (derepressed Nodal,
Pitx2) were suggested to be transcriptionally upregulated upon loss
of Ring1b. Genome-wide binding studies have identified that PcG
proteins are associated with members of the TGFbeta signaling
pathway and show PcG dissociation from the genes that were
Figure 4. Gene expression profiling in Ring1b-deficient ES cells. (A) Expression profiling data clustered by the software program Genesis
shows regulation of gene expression (p,0.05) after deletion of Ring1b in mouse ES cells over time. (B) Graph representing the number of all
upregulated (red) and downregulated (green) genes (p,0.05). (C) Graph representing the number of up- (red) or downregulated (green) Ring1b
bound genes specifically [21]. (D) QPCR validation of microarray data for a selection of genes. Time indicates number of days of 4-OHT treatment. (E)
Heatmap of the statistically overrepresented GO categories, as identified by BiNGO analysis. The color scale bar represents the relation between the
color intensity and the level of significance (–log10(p-value)). (F) Table showing the significantly enriched GO categories and the percentage
(numbers between brackets) of up- or downregulated genes and the number of Ring1b bound genes per GO category (the ones most-downstream
in the GO-tree, see also Figure S2).
doi:10.1371/journal.pone.0002235.g004
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role for Ring1b/PcG in direct repression of TGFbeta signaling in
ES cells.
In agreement with the GO classification analysis, we found
altered expression of several components of the cell cycle pathway.
Changes in cell cycle regulation have been observed following
differentiation of ES cells, characterized by amongst others
activation of the pRb-E2f controlled G1 checkpoint, which is
inoperative in ES cells [37,38]. In line with this, key cell cycle
regulators involved in activation of the G1/S checkpoint
(derepressed Cdkn1c; downregulated E2f1, Cdc7 and Mcm6) were
transcriptionally deregulated. However, deregulation of other key
cell cycle genes suggest promotion of S phase (derepressed Ccnd2/
Cyclin D2 and Cul1), G2/M arrest (derepressed Gadd45g and Sfn/
14-3-3-sigma) or bypass of G2/M arrest (downregulated Gadd45a)
and mitotic exit (derepressed Cdc20 and Cdc27). This could imply
Table 1. A selection of the deregulated genes and corresponding pathways affected in Ring1b-deficient ES cells.
Symbol EntrezID Regulation bound Symbol EntrezID Regulation bound
Focal Adhesion TGFbeta signaling
Actg2 11464 up 0 Amhr2 110542 down ND
Actn3 11474 down 0 Bmp7 12162 up 1
Capn2 12334 up 0 Bmpr1a 12166 up 0
Capn5 12337 down 0 Cul1 26965 up 0
Ccnd1 12443 up 0 Id1 15901 up 0
Ccnd2 12444 up 1 Id2 15902 up 0
Col4a2 12827 up 1 Id3 15903 up 1
Grb2 14784 down 0 Lefty1 13590 up 0
Ilk 16202 up 0 Mapk3 26417 down ND
Nras 18176 down 0 Nodal 18119 up 0
Pdgfc 54635 up ND Pitx2 18741 up 0
Pten 19211 up 0 Thbs1 21825 up 0
Rras2 20130 down 0
Shc2 216148 down ND Cell cycle
Thbs1 21825 up 0 Anapc10 68999 up 0
Vegfa 22339 down 0 Ccnd2 12444 up 1
Zyx 22793 up 0 Cdc20 107995 up 0
Cdc27 217232 up 0
Gap junction Cdc7 12545 down 0
Itpr1 16438 down 0 Cdkn1c 12577 up 1
Adcy2 210044 up 1 Chek1 12649 down 0
Csnk1d 104318 up 0 Cul1 26965 up 0
Edg2 14745 down 0 Gadd45a 13197 down 0
Gja1 14609 up 1 Gadd45g 23882 up 1
Grb2 14784 down 0 Mcm6 17219 down 0
Nras 18176 down 0 Sfn 55948 up ND
Pdgfc 54635 up ND Smc1l2 140557 down 0
Rras2 20130 down 0
Adherens junctions
Actn3 11474 down 0
Baiap2 108100 up 0
Iqgap1 29875 up 0
Lmo7 380928 down ND
Mapk3 26417 down ND
Pvrl4 71740 down 0
Vcl 22330 down 0
Wasl 73178 up 0
DAVID Pathway analysis revealed the pathways deregulated in Ring1b-deficient ES cells. Shown are the deregulated genes per pathway, their EntrezIDs, the
deregulated expression state, and binding of Ring1b to the promoter (1=bound, 0=not bound, ND=no data). For a complete overview of all identified pathways see
Table S3.
doi:10.1371/journal.pone.0002235.t001
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which is supported by the observation that Ring1b is involved in
direct repression of cell cycle promoting gene Ccnd2 and cell cycle
inhibitory genes Cdkn1c and Gadd45g.
Various components of cellular communication pathways were
deregulated in the absence of Ring1b. These comprise ECM genes
(derepressed Col4a2 and Thbs1) involved in focal adhesion, gap
junction genes (derepressed Gja1 and Csnk1d and downregulated
Itpr1), and adherens junction pathways, which are linked to the actin
cytoskeleton organization (downregulated Vcl and Actn3, derepressed
Iqgap1). Several of these genes were reported to change expression
during differentiation and development [39–41].
Summarizing, this suggests that Ring1b deficiency induces
changes in cellular pathways, such as Bmp/TGFbeta signaling,
cell cycle regulation, and cellular communication, which strongly
suggests a link to differentiation programs in ES cells.
Retained expression of stem cell regulators in Ring1b-
deficient ES cells
ES cells, derived from the epiblast of early blastocysts, can self-
renew and maintain a pluripotent, undifferentiated state in vitro by
extrinsic factors, such as LIF and Bmp, and intrinsic factors,
including stem cell regulators Oct4 and Nanog [42–45]. Upon
induction of lineage-specific genes, these stem cell regulators are
downregulated through a negative-feedback-loop by not yet
understood mechanisms [42,45,46]. In line with this, the transcript
levels of stem cell specific genes Sox2, Dppa3/Stella and Zfp42/Rex-1
were strongly downregulated in Ring1b-deficient ES cells [43,47]
(Figure 4D, Table S1). However, QPCR analysis showed that Nanog
transcript levels had not altered and Oct4 transcript levels had
reduced only to about 55% (Figure 4D). Importantly, Oct4 was not
identified as an outlier on the microarray and Western blot analysis
showed no significant changes in Oct4 protein levels (Figure 3A,
Table S1). To examine Oct4 expression in more detail, we also
quantified the immunofluorescence levels of Oct4 and Ring1b
stainings in individual cells. We compared this to guided neural
differentiation induced by retinoic acid (RA) treatment, which was
demonstrated to resultinsignificantdownregulation ofOct4[48].As
expected, we found that three days after RA induced neural
differentiation Oct4 was completely downregulated, inabout 65% of
the cells (Figure 5A, 5B). However, whereas four days following
Ring1b deletion, 81% of all cells were negative for Ring1b, only 5%
had lost Oct4 expression (Figure 5A, 5B, 5C). To assess the extent of
neural differentiation, we next examined the expression of neuronal-
lineage marker Nestin [49]. We found that three days after RA
treatmentapproximately 44%of the cellsshowed filamentousNestin
staining, compared to 32% of the cells after deletion of Ring1b
(Figure 5D, 5E). This is remarkable considering the number of cells
expressing Oct4.Thissuggeststhat expression of lineage markers co-
exists with stem cell regulators in absence of Ring1b in ES cells.
Finally, we examined the activity of alkaline phosphatase, which is
highly expressed in undifferentiated, pluripotent ES cells [50]. We
found that after deleting Ring1b a substantial number of cells still
showed high activity of alkaline phosphatase compared to RA
treated ES cells, which is indicative for a pluripotent, undifferenti-
atedstateofEScells(Figure5F).Combined,ourfindingssuggestthat
Ring1b-deficient ES cells show features of differentiated cells, while
retaining important ES cell characteristics.
Ring1b represses genes that are co-occupied by stem cell
regulators Oct4 and Nanog in ES cells
The stem cell-specific transcription factors Oct4 and Nanog
control ES cell pluripotency by regulating expression of stem cell
specific genes and repression of differentiation-specific genes, of
which a subset is co-occupied by PcG proteins [25,43,51].
Considering the retained expression of Oct4 and Nanog, we were
interested to see the effect on gene transcription of these co-
occupied genes in absence of Ring1b. We therefore analyzed the
changes in expression of genes that were bound by Ring1b [21]
and by Oct4 and/or Nanog in mouse ES cells as was identified by
Loh and co-workers [51]. We found that the expression of 25 of
the 212 Nanog/Oct4/Ring1b bound genes represented on our
microarray was altered in Ring1b-deficient ES cells (Figure 4D,
Table S1). We found that 18 of these 25 genes were derepressed,
including Fgf15, Bmp7, Gata3, Bmi1, Msx2, Podxl, Col4a2, Gadd45g,
Gja1 and Eif4g3. This suggests that Ring1b is required to repress a
specific subset of Oct4 and Nanog bound genes to maintain a
pluripotent, undifferentiated ES cell state.
Ring1b represses bivalent or H3K4me3 marked genes
with CpG-rich promoters
Ring1b-mediated H2A mono-ubiquitination was shown to
restrain a poised RNAPII configuration specifically at the
promoters of bivalent genes, which were derepressed upon loss
of Ring1b and uH2A [31]. Therefore, we investigated the
chromatin state of the genes that were deregulated in absence of
Ring1b in ES cells. Hereto, we used a data set from Mikkelsen and
colleagues, who generated genome-wide chromatin-state maps for
mouse ES cells, neural progenitor cells (NPC) and MEFs [30]. Of
948 of the 1078 Ring1b bound genes [21] represented on our
microarray chromatin-state maps were retrieved for the histone
modifications H3K4me3 and H3K27me3 [30]. Notably, virtually
all (99%) of the Ring1b bound genes that were mapped as marked
with both H3K27me3 and H3K4me3 or H3K27me3 alone,
according to Mikkelsen-data set [30], were associated with
H3K27me3 according to the H3K27me3 mapping data by Boyer
et al [21], indicating a strong overlap between the two data sets for
this histone mark. The chromatin-state maps also contain
information about the CpG content of promoters genome-wide.
Mikkelsen and colleagues show that genes with high-CpG content
promoters (HCP) and H3K4me3 marks generally have ‘house-
keeping’ functions, including replication and basic metabolism,
while genes with HCP and bivalent marks mainly include key
developmental transcription factors, morphogens, and cell surface
markers. Genes with low-CpG content promoters (LCP) are
associated with highly tissue-specific genes. A third class of genes
with intermediate CpG promoter content (ICP) was added to
ensure discrimination between the HCPs and LCPs.
Comparative analysis showed that about two-third of the
promoters genome-wide, i.e represented on our microarrays, or
differentially regulated in Ring1b-deficient ES cells, had HCPs
(Figure 6A, 6B). Remarkably, Ring1b almost exclusively associated
with and regulated transcription of genes with HCPs (93%; 882/
948 and 94%; 119/126, respectively; Figure 6C, 6D). This
suggests that Ring1b primarily regulates transcription of CpG-
‘rich’ promoters.
We next analyzed the chromatin state of the Ring1b bound
genes with HCPs. We found that these genes were strongly
associated with bivalent marks (74%; 653/882). A similar fraction
of deregulated Ring1b bound genes with HCPs was bivalently
marked (73%; 87/119; Figure 6E). These deregulated bivalently
marked Ring1b bound genes included mostly developmental
genes, such as Bin1, Bmi1, Bmp7, Col4a2, Ccnd2, En1, Gata3, Lmx1a
and Wnt6, and were predominantly derepressed in absence of
Ring1b (86%; 75/87; Figure 6H, 6I). Interestingly, we found that
Ring1b was also associated with a considerable number of HCPs
with the H3K4me3 mark alone (25%; 218/882; Figure 6E). The
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PRC2, implies that Ring1b might be recruited independent from
PRC2 for these genes in ES cells. Of the deregulated H3K4me3
marked Ring1b bound genes with HCPs 66% (21/32) was
derepressed, including Eif4g3, Gja1 and Sgce, and various histone
encoding genes, such as Hist1h2bn, Hist1h2bf, Hist1h3i, Hist1h4h,
and Hist1h4f (Figure 6J, 6K). Not all promoters associated with the
active H3K4me3 mark are actively transcribed [30]. Considering
the fact that Ring1b is a transcriptional repressor, we predicted
that the H3K4me3 marked genes with relative low expression
levels were bound by Ring1b. We therefore examined the RNA
expression levels of these genes in wild type ES cells by using the
Affimetrix RNA expression data that was available in the
chromatin-state mapping study by Mikkelsen et al. [30].
Unexpectedly, Ring1b binding did not correlate with low
expression levels of H3K4me3 marked genes, but instead seemed
to associate with these actively marked genes indifferent of their
level of expression (Figure 6G). Notably, in more committed NPCs
and MEFs (89% and 83%, respectively) most of the Ring1b bound
H3K4me3 marked genes retain this histone mark and corre-
Figure 5. Ring1b-deficient ES cells retain expression of stem cell specific regulators. (A,D) Examples of immunofluorescence stainings in
Ring1b
2/Lox;CreER
T2 ES cells of (A) Oct4 (red) and DAPI (blue), and (D) Nestin (green) and DAPI (blue), either untreated (upper panels) or treated for four
dayswith4-OHT (middlepanels)orthree dayswithRA(lowerpanels). (B,C) Histograms representthe distributionofthe meanimmunofluorescencelevels
per cell retrieved after quantification of immunofluorescence stainings of Oct4 (B) or Ring1b (C) in Ring1b
2/Lox;CreER
T2 ES cells either untreated, or treated
for fourdayswith4-OHT or three days withRA.(E) Graph representing the number ofRing1b
2/Lox;CreER
T2EScells either untreated, ortreated for four days
with4-OHTorthreedays withRAthatshowubiquitous(blackbars)orfilamentous(grey bars)Nestinstaining.(F)Alkalinephosphataseactivitystainings in
Ring1b
2/Lox;CreER
T2 ES cells either untreated, or treated for four days with 4-OHT or three days with RA.
doi:10.1371/journal.pone.0002235.g005
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maps generated for these cell types [30] (Figure S3). In contrast, of
the bivalently marked genes only 11% and 51% retain both histone
marks in NPCs and MEFs, respectively [30] (Figure S3), indicating
that Ring1b does not act to silence the H3K4me3 marked genes in
ES cells or during development. Although we cannot exclude that
differentiation-associated changes affect transcription of the Ring1b
bound genes, these data suggest that Ring1b predominantly
represses bivalent genes, and is also involved in modulating, rather
than silencing, the transcriptional activity of genes with the active
H3K4me3 histone mark in ES cells.
Strikingly, a specific subset of Ring1b bound genes was not
affected following Ring1b deletion. This subset contains LCPs,
which were all without H3K27me3 or H3K4me3 marks, and
bivalently marked genes with ICPs (Figure 6D, 6F). This implies
that other mechanisms are involved in regulation of these genes in
ES cells.
Summarizing, these data suggest that Ring1b is involved in
direct regulation of RNAPII controlled promoters with ‘high’ CpG
content and epigenetically distinct histone marks, namely bivalent
marks or the active H3K4me3 mark, in mouse ES cells.
Discussion
To investigate the role of Ring1b in mouse ES cells, we
employed a conditional knockout system. By performing micro-
array analysis, we studied the genome-wide changes in gene
transcription that occur following Ring1b deletion in ES cells. We
Figure 6. Deregulation of genes bivalent or H3K4me3 marked genes with HCPs in Ring1b-deficient ES cells. (A–D) Circle graphs show
that Ring1b primarily occupies (C) and regulates (D) transcription of genes with high CpG content promoters (HCPs) rather than intermediate (ICP) or
‘low’ (LCP) CpG content promoters, compared to the distribution of HCPs in all genes (A) or only the deregulated genes (B) at the microarray
(‘genome-wide’). (E) Bar graph showing the distribution (percentages) of the chromatin state of HCPs for all genes on the whole microarray (‘genome-
wide’); only the genes deregulated in absence of Ring1b; Ring1b bound genes; only deregulated Ring1b bound genes in Ring1b-deficient ES cells.
Graph shows that Ring1b binds and regulates transcription of bivalent, and to a lesser extend H3K4me3 marked genes (final two columns), in
contrast to the genome-wide distribution of these marks on promoters (first two columns). (F) as (E), but for genes with ICPs. Graph shows that
bivalent Ring1b bound genes with ICPs are not deregulated in Ring1b-deficient ES cells. (G) Blotplot representing Affimetrix array data of RNA
expression levels in wild type ES cells [30], for the genes represented in (E). The blotplot shows that the median expression levels of H3K4me3 marked
genes on the whole microarray (‘genome-wide’ ) are higher compared to the median RNA expression levels of H3K4me3+H3K27me3 marked genes
(first two columns). This is similar for genes that are bound by Ring1b (middle two columns), and for Ring1b bound genes that are deregulated in
Ring1b-deficient ES cells (last two columns). Black diamond represents median RNA expression level. (H–K) Line graph showing changes (log2 ratio) in
gene expression of bivalently (H–I) or H3K4me3 (J–K) marked genes bound by Ring1b following deletion of Ring1b in Ring1b
2/Lox;CreER
T2 ES cells.
Time is indicated in number of days of 4-OHT treatment.
doi:10.1371/journal.pone.0002235.g006
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were derepressed, including a subset of genes bound by stem cell
regulators Oct4 and Nanog, suggesting that Ring1b deficiency
results in activation of the differentiation program. Accordingly,
specific differentiation-related pathways were differentially dereg-
ulated, including TGFbeta signaling, cellular communication and
cell cycle pathways. Importantly, retained expression of stem cell
regulators Oct4 and Nanog indicates that Ring1b-deficient ES
cells still have important ES cell specific characteristics. Based on
re-analysis of previously published global binding studies per-
formed in mouse ES cells, we found that Ring1b predominantly
binds and represses genes with CpG-‘rich’ promoters. Further-
more, these genes are associated with bivalent domains or the
H3K4me3 histone mark alone. We suggest that Ring1b
contributes to stable maintenance of pluripotency of ES cells by
repressing bivalently or actively marked genes.
We found that Ring1b is required to repress the differentiation
program in ES cells, which is consistent with the observation that
Ring1b-deficient ES cells are prone for differentiation [34].
Comparative analysis with genome-wide Ring1b binding data of
mouse ES cells [21], indicated that Ring1b is involved in direct
transcriptional regulation of key developmental genes, such as
Bmp7, Gata3 and Msx. This is in agreement with other genome-
wide and candidate-based PcG binding studies performed in
mouse and human ES cells [21,24–28,34]. Notably, by directly
repressing these extracellular and down-stream effector compo-
nents of differentiation-related pathways, such as Bmp7 and Id3 of
the Bmp/TGFbeta signaling pathway, and Col4a2, Gja1 and Ccnd2
of the cellular communication pathways, Ring1b may have an
important role in influencing lineage choice and other develop-
mental events. For example, expression of ECM protein Col4a2
was shown to induce mesodermal differentiation of ES cells in vitro,
while repression of Bmp7 at the dorsal site of zebrafish gastrula
was shown to allow cellular migration as is required for limb
development. [52,53]. In Ring1b knockout embryos, several
developmental markers are misexpressed at early gastrulation
stages, extraembryonal mesoderm is over-represented, epiblast has
expanded improperly, and embryonic growth is delayed [17]. This
is in line with the aberrant expression of developmental markers
and induction of apoptosis observed in Ring1b knockout ES cells.
The early embryonic lethality is partially rescued in a Cdkn2a-
knockout background, one of the PcG transcriptional targets
[54,55], resulting in the delay of embryonic death of about 4 days
[17]. Since relief of the Ink4a/Arf-mediated antiproliferative block
only bypasses the proliferative defects induced by loss of Ring1b,
this underscores the importance for Ring1b in regulating
developmental genes during early embryogenesis.
The observation that only a subset of Ring1b bound genes is
derepressed following deletion of Ring1b in ES cells, suggests that
additional mechanisms mediate silencing of the other Ring1b
target genes. This would be in correspondence with observations
by others, who show that only part of the PcG bound genes are
deregulated after RNAi-mediated depletion of PcGs in human
embryonic fibroblasts and in ES cells deficient for Eed or Suz12
[20,21,26]. Partial derepression could be also be explained by
functional redundancy by related Ring1a, which possess ubiquitin
E3 ligase activity towards histone H2A, alike Ring1b, although
with less efficiency [56–58]. In addition, the composition of PRCs
can vary per tissue and developmental stage [20,27,56,59].
Therefore, Ring1b might not be essential in every promoter-
bound PcG repressive complex.
We found that Ring1b represses genes that are co-occupied by
Oct4 and Nanog. This is consistent with earlier reports, which
show a role for PcG proteins in repressing a set of developmental
genes that are bound by Oct4 and Nanog in ES cells [25,51]. A
possible link between these proteins is provided by Wang and
colleagues, who co-purified Oct4, Yy1 and Ring1b with stem cell
specific protein Rex-1 from ES cells [60]. In Drosophila, PcG-
specific sequences (named polycomb group responsive elements or
PREs) mediate PcG repression [61]. However, in mammalians,
PREs or sequence-specific DNA binding PcG proteins have not
been identified. Therefore, one might speculate that recruitment of
PcG-silencing complexes to specific genes involves interactions
with site-specific DNA-binding factors. This could be the
recruitment of the PcG silencing complex to key developmental
genes through interaction with stem cell specific factors Rex-1
and/or Oct4 in order to maintain an undifferentiated state of ES
cells. This suggestion is supported by the observation that Suz12
dissociates from PcG/Oct4 co-occupied promoters upon down-
regulation of Oct4 [20]. Interestingly, others have found that
histone H2A E3 ligase 2A-HUB, but not RING1B, is selectively
required for H2A mono-ubiquitination and subsequent repression
of chemokine genes following recruitment by co-repressor N-CoR
in human monocytes [32]. Together, this suggests that different
site-specific factors are involved in the recruitment of distinct H2A
E3 ligases to mediate repression of a specific set of genes.
Ring1b-deficient ES cells retain expression of important stem
cell regulators Oct4, Nanog and alkaline phosphatase, which was
also observed in other PcG-deficient ES cells [20,31,34].
Derepression of developmental genes and downregulation of other
stem cell markers, such as Rex-1, Sox2 and Dppa3, suggests
activation of the differentiation program. During ES cell
differentiation, repression of Oct4 and Nanog is essential,
considering that ectopic expression of Oct4 can block differenti-
ation, while expression of Nanog is enough to maintain ES cell
self-renewal and pluripotency, even in the absence of extrinsic
factor LIF or Oct4 expression [44,45,62]. Retained expression of
Oct4 and Nanog could indicate that PcG proteins are either
directly or indirectly involved in regulation of Oct4 and Nanog. A
direct role for PcG proteins in regulating the expression of Oct4
and Nanog has been suggested by Pasini and co-workers, who
show that PRC2 proteins bind to the Oct4 and Nanog promoters
in ES cells [20]. Moreover, the H3K27me3 histone mark has been
found at the Oct4 promoter in more committed cells, suggesting
that PcG proteins are involved in direct repression of stem cell
regulators in differentiated cells [28].
Comparative analysis of our expression profiling data with
recently published global chromatin-state maps generated of
mouse ES cells showed that Ring1b almost exclusively binds to
genes with CpG-rich promoters. This is in consistent with a report
showing that a strong correlation exists between promoters with
highly conserved large CpG islands and Suz12 binding domains in
undifferentiated human ES cells [63]. Furthermore, our data
confirm that PcG proteins are involved in repressing bivalently
marked developmental genes in ES cells [28–31]. This compar-
ative analysis also revealed that a considerable number of actively
transcribed H3K4me3 marked Ring1b bound genes are regulated
(mainly repressed) in ES cells. The absence of H3K27me3 at these
promoters suggests that Ring1b is recruited independently from
PRC2. This is in agreement with other observations indicating
that Xist RNA, but not PRC2, is required for PRC1 recruitment
during X inactivation in differentiating ES cells [10]. The
association of Ring1b to actively transcribed genes is consistent
with global and candidate-based binding studies that show overlap
between PcG and RNAPII occupancy or association of PcG
proteins with expressed genes in mouse and human ES cells,
neural progenitor cells and embryonic fibroblasts [20,25–27,64].
This suggests that Ring1b does not function as a silencer of these
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genes retain this mark and corresponding transcriptional state in
more committed NPCs and MEFs [30]. Thus, rather than poising
for activation or prolonged inactivation, as was proposed for the
bivalent genes, Ring1b might be required to modulate the
transcriptional activity of this subset of actively marked genes in
ES cells and during later developmental stages. Only recently,
association of Ring1b and uH2A was shown to mediate a silenced
state of RNAPII present at promoters and coding regions of
bivalent genes [31]. Dissociation of Ring1b and uH2A from these
promoters results in activation of the RNAPII complex without
major changes in the levels of PRC2 proteins or association of
H3K27me3. In addition, others showed that the presence of
uH2A in the promoter-proximal region blocks recruitment of
FACT resulting in pausing of RNAPII and inhibition of
transcriptional elongation [32]. One could speculate that
Ring1b-mediated mono-ubiquitination of histone H2A also
interferes with the RNAPII complex at active H3K4me3 marked
genes, but how remains to be investigated.
Altogether, our data suggest that Ring1b is important to
maintain an undifferentiated state of ES cells through repression of
key developmental genes. The finding that this involves direct
transcriptional repression of at least two epigenetically distinct sets
of genes helps to understand and further explore the role of
Ring1b during development.
Materials and Methods
Generating Ring1b conditional knockout ES cells
The Ring1b wild type allele in Ring1b
+/2 ES cells [17] was
targeted with a construct containing loxP sequences at the EcoRI
site in intron 2 and at the XhoI site in intron 4, followed by a third
LoxP site enclosing a hygromycin cassette to allow for selection of
targeted ES cells. Correct targeting of hygromycin resistant
Ring1b
2/LoxHyg ES cell clones was confirmed by Southern blot
analysis. Next, to obtain Ring1b
2/Lox ES clones the hygromycin
cassette was removed by transiently expressing adenoviral Cre and
subsequently screening for hygromycin sensitivity. Correct remov-
al of the hygromycin cassette in the selected Ring1b
2/Lox ES clones
was confirmed by Southern blot analysis. Finally, to generate
inducible conditional Ring1b
2/Lox;CreER
T2 ES cells a puromycin-
selectable R26CreER
T2 construct was targeted to the ROSA26
locus. CreER
T2 could be activated by adding 200 nM 4-OHT
(Sigma, dissolved in absolute ethanol) to the ES cell medium.
Southern blot analysis of HindIII digested genomic DNA and a
59end external probe in intron 1 to discriminate between the
Ring1b wild type (11 kb), conventional knockout (5 kb)[17], Lox (7
kb), and Del (4 kb) allele. The Del allele follows from deletion of
exons 3 and 4 after 4-OHT-mediated activation of CreER
T2 in
Ring1b
2/Lox;CreER
T2 ES cells.
Cell culture
ES cells were cultured on dishes coated with 0.1% gelatin
(Sigma) without feeders in 60% conditional Buffalo Rat Liver
(BRL) medium, which consisted of 60% BRL medium and 40%
standard ES medium. Standard ES cell medium consisted of
GMEM (Gibco), 10% foetal calf serum (Sigma), supplemented
with 1% non-essential amino acids, 1 mM sodium pyruvate, L-
glutamate, 0.1 M beta-mercaptoethanol and 10
3 units LIF (all
Gibco). BRL medium was derived by filtering (0.2 uM) the
supernatant of BRL cells cultured for one week in standard ES cell
medium without beta-mercaptoethanol or LIF.
Ring1b conditional ES cells or Ring1b
+/+;CreER
T2 control ES
cells were treated with 200 nM 4-OHT and MEFs with 1 mM4 -
OHT for the indicated time. MEFs were isolated from 14.5 day
old embryo’s and cultured as described before [55]. For RA
treatment ES cells were cultured in standard ES medium
without LIF and in the presence of 500 nM all-trans-RA (ATRA)
(Sigma).
Protein isolation and Western blot analysis
Proteinswereextractedfromwholecells(RIPAlysates,protocolas
described previously) [65] or from the nucleus (nuclear extraction).
FornuclearextractscellswerewashedwithPBS,incubatedonicefor
5 min in Triton lysis buffer (0.1 M NaCl, 0.3 M sucrose, 3 mM
MgCl2,50 mMHEPESpH 6.8,1 mMEGTA,0.2%Triton-X100)
supplementedwithCompleteproteaseinhibitorcocktailand10 mM
N-ethylmaleimide (NEM) followed by spinning at for 5 min
3000 rpm at 4uC to pellet the nuclei. Nucleic proteins were
recovered by incubating the nuclei in SDS-lysis buffer (0.1% SDS,
50 mM TrisHCl pH 7.5, 0.15 M NaCl) for 10 min on ice, followed
by sonification (10 pulses at 50%, level 4) and spinning for 1 min at
14.000 rpm to remove insoluble material. Protein samples were
assayed with SDS-PAGE using pre-cast gradient gels (Invitrogen)
and conventional Western blotting techniques.
Immunostaining, alkaline phosphatase, and Annexin V
staining
ES cells were cultured four days with 200 nM 4-OHT or three
days with 500 nM RA on coverslips coated with 0.1% gelatin.
Cells were fixed in 4% paraformaldehyde for 10 min at RT and
permeabilization in 0.25% Triton-X100/PBS for 5 min. Cells
were then incubated for 30 minutes at RT in blocking solution
(5% foetal calf serum (Gibco), 5% normal goat serum (Vector
laboratories), 0.02% Triton-X100/PBS). Next, cells were incubat-
ed with the 1
st antibody for 1 hour at RT in blocking solution and
afterwards washed five times 5 minutes with 0.02% Triton-X100/
PBS. Hereafter, cells were incubated for 1 hour at RT with
fluorescence labeled 2
nd antibody in blocking solution, followed by
five washes of 5 min each with 0.02% Triton-X100/PBS. Cover
slips were mounted on object slides using Vectashield with DAPI
(Vector Laboratories). For the uH2A immunostaining cells were
permeabilized prior to fixation by in cytoskeletal buffer (100 mM
NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM PIPES pH6.8) for
30 sec, followed by 30 sec in cytoskeletal buffer containing 0.5%
Triton-X100, and 30 sec in cytoskeletal buffer without Triton-
X100, all on ice.
For the alkaline phosphatase staining cells were cultured on
dishes, followed by fixation and stained according to the
manufactures protocol (Sigma).
To determine the level of apoptosis, cells were collected by
trypsinization, or first washed twice with PBS to obtain only the
adherent cells, followed by staining with FITC-conjugated
Annexin V-FITC (Roche) according to the manufactures protocol
and analyzed by flow cytometry.
Antibodies
H3K27me3 rabbit polyclonal was a kind gift from T. Jenuwein.
Ezh2 mouse monoclonal antibody was a kind gift from K. Helin.
Ring1b mouse monoclonal and rabbit polyclonal antibodies were
obtained from H. Koseki. Oct4 mouse monoclonal antibody C-10
and Lamin-B goat polyclonal antibody M20 from Santa Cruz,
Nestin mouse monoclonal antibody from BD, Eed rabbit
polyclonal and Bmi1 and uH2A mouse monoclonal antibodies
from Upstate. Secondary immunofluorescence antibodies were
Alexa 488- or 568-conjucated anti-mouse, 568- or 488-conjucated
anti-rabbit from Molecular Probes.
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To quantify the fluorescence levels of immunofluorescence-
labeled proteins in individual cells, we took sequential images of
DAPI and the fluorescence labeled protein using a Leica confocal
research microscope with a 63x lens and fixed laser settings per
protein. Files were saved in TIFF format with 5126512
resolution. The images were analyzed with Image-Pro 5.1
software (Media Cybernetics). In brief, mean fluorescence
intensity levels of the immunofluorescence-labeled protein per
cell were measured for the nucleic area as was determined by the
DAPI staining for on average 250 cells per quantification and
three independent stainings. The distribution of the mean
intensity per cell is displayed in histogram figures with same x-
axis scale.
RNA isolation, real-time QPCR and microarray analysis
Ring1b
2/Lox;CreER
T2 and Ring1b
+/+;CreER
T2 control ES cells
(used as a reference for QPCR and microarray) were cultured
under the same conditions and RNA was isolated at the indicated
time points. Total RNA was isolated using TRIzol reagent
(Invitrogen) according to the manufactures protocol followed by
DNase treatment and aRNA amplification (Invitrogen). Real-time
QPCR conditions and primer sequences are as described
elsewhere [21]. Changes in RNA levels following 4-OHT
treatment of Ring1b
2/Lox;CreER
T2 relative to Ring1b
+/+;CreER
T2
ES cells were determined based on the results of three QPCRs.
The oligonucleotide arays were printed at the CMF core facility
of the NKI/AvL with mouse Operon microarray version 3
(http://microarrays.nki.nl/download/geneid.html). Detailed in-
formation about the labeling and hybridization protocols and
array analysis can be found on the NKI/AvL microarray website
(http://microarrays.nki.nl/download/protocols.html). In brief,
amplified RNA was labeled with ULS Cy5 or Cy3 (Kreatech
EA-006, Amsterdam) was pooled and co-hybridized to the
microarray (each experiment was performed in dye swap fashion
and controlled with self-self hybridization experiments to correct
for dye-bias). After 16 hours of hybridization the microarrays were
washed and scanned using an Agilent DNA Microarray scanner
(Agilent Technologies, Cat# G2505B). ImaGene v6.0 software
(BioDiscovery Inc) was used to quantify the RNA expression levels
using the tiff images produced by the scanner. The background-
corrected intensities from the Cy5- and Cy3 channel were used to
calculate log2 transformed ratios. These ratios were normalized
using a lowest fit per subarray [66]. A weighted average ratio and
confidence level (P-value) was calculated per gene by a NKI
platform adjusted error model [67], which was fine-tuned by self-
self hybridizations. Significantly differentially expressed genes
(outliers) between sample and reference were selected based on
their P-value (a gene with a P-value ,0.05 was considered an
outlier).
The microarray details and results are submitted to the
ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/), ref-
erence number E-NCMF-14. Clustering of the microarray data
was performed using the bioinformatics software program Genesis
[68]. GO classification analysis was performed using bioinfor-
matics program BiNGO [36]. Pathway analysis was performed
using the bioinformatics software program DAVID based on the
KEGG pathway database available online (http://david.abcc.
ncifcrf.gov).
Supporting Information
Figure S1 Loss of uH2A after deletion of Ring1b in MEFs.
Example of immunofluorescence stainings of Ring1b-/Lox;-
CreERT2 MEFs 6 days following 4-OHT treatment showing loss
of uH2A in MEFs that have lost Ring1b.
Found at: doi:10.1371/journal.pone.0002235.s001 (4.21 MB TIF)
Figure S2 Graphical representation of GO categories that are
significantly enriched in Ring1b-deficient ES cells. Graphical map
showing the hierarchical relations between the significantly
enriched GO categories (yellow circles) identified by the BiNGO
bioinformatics tool based on the outliers per day of 4-OHT
treatment of Ring1b-/Lox;CreERT2 ES cells.
Found at: doi:10.1371/journal.pone.0002235.s002 (0.32 MB PDF)
Figure S3 Ring1b bound H3K4me3 marked genes with CpG-
rich promoters retain this mark in NPC and MEFs. Bar graph
showing the distribution of the chromatin-state of the Ring1b
bound genes with high-CpG content promoters (HCP) in neural
progenitor cells (NPC) or MEF that were marked with either
H3K4me3 or H3K4me3+H3K27me3 in ES cells. Graph
represents the chromatin state of all Ring1b bound genes that
are represented on the microarray (‘all’), and only the Ring1b
bound genes that are deregulated in Ring1b deficient ES cells
(‘dereg’). These data show that most H3K4me3 marked genes,
retain this mark in NPC and MEFs.
Found at: doi:10.1371/journal.pone.0002235.s003 (0.59 MB TIF)
Table S1 Expression Profiling data of Ring1b-deficient ES cells.
Excel file of expression profiling data of Ring1b-deficient ES cells,
coupled to Ring1b binding data according to Boyer and co-
workers (Nature, 2006), based on EntrezIDs.
Found at: doi:10.1371/journal.pone.0002235.s004 (7.49 MBXLS)
Table S2 BiNGO ontology analysis of genes deregulated in ES
cells. Excel file of BiNGO analysis of all outliers based on
EntrezIDs per day of 4-OHT treatment of Ring1b-/Lox;-
CreERT2 ES cells.
Found at: doi:10.1371/journal.pone.0002235.s005 (0.06 MBXLS)
Table S3 Pathway analysis of genes transcriptionally deregulat-
ed following Ring1b deletion. Excel file of DAVID pathway
analysis (selecting the KEGG pathway database option) of all
outliers, based on EntrezIDs, per day of 4-OHT treatment of
Ring1b-/Lox;CreERT2 ES cells.
Found at: doi:10.1371/journal.pone.0002235.s006 (0.02 MBXLS)
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